Thereafter, SNHG6 was shown to sponge miR-101 in gastric (36), glioma (41), colorectal (42), non-small cell lung (43), cholangiocarcinoma (44), melanoma (45) and esophageal (46) cancer cells. This evidence concerns the gene SNHG6 and central nervous system cancer.